my.chemie.de
With an accout for my.chemie.de you can always see everything at a glance – and you can configure your own website and individual newsletter.
Eberhard-Karls-Universität Tübingen, Pharmazeutische Technologie und Biopharmazie
studied pharmacy at the University of Tübingen and was awarded his doctorate in 1984. Following a one-year period of research at the Karolinska Institutet in Stockholm, he completed his habilitation in pharmacology and toxicology in 1995. In 1998, he moved to the University of Tübingen’s Pharmaceutical Technology and Biopharmacy department to take up teaching and research duties as a senior lecturer and head of the biopharmacy research group. In 2001, he was appointed supernumerary professor. Alongside supercritical fluids, his fields of interest include the active cellular uptake of APIs, as well as research issues of interest in pharmacokinetics and biopharmaceutics. Martin Wahl is also responsible for the structure and organisation of the master’s degree course in Pharmaceutical Sciences and Technologies, and manages the alternative examination procedure for the first stage in pharmaceutical examinations at Tübingen.
As a general rule, the pharmaceuticals industry develops new drugs by applying a complex procedure of formulation utilising excipients suitable for the final drug dosage form. Such (…)
Tackling the collateral damage from antibiotics
Antibiotics help us to treat bacterial infections and save millions of lives each year. But they can also harm the helpful microbes residing in our gut, weakening one of our body’s first lines of defence against pathogens and compromising the multiple beneficial effects our microbiota has f ... more
Fungus produces active agent in a medicinal herb
Tatarinow's aster is used in traditional Chinese medicine to treat a number of ailments; the plant contains an active ingredient known as astin – and it is this agent which cancer researchers are now investigating. However, the plant does not produce the astins itself, as was assumed for a ... more
Making cancer stem cells visible to the immune system
Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. In the journal "Nature", scientists from Basel, Tübingen and Heidelberg describe the new therapeutic approaches that can ... more
Putting Pressure on Pharmaceuticals
As a general rule, the pharmaceuticals industry develops new drugs by applying a complex procedure of formulation utilising excipients suitable for the final drug dosage form. Such development processes are carried out by the companies’ technical departments and in many cases result in solu ... more
Geoscientists, biologists and chemists at the University of Tübingen are working in collaboration with IFAM (Fraunhofer Institute for Manufacturing Technology and Advanced Materials in Bremen, Germany) to uncover the workings of insect surface adhesion. The goal of this project is the synth ... more
Michael Lämmerhofer studied pharmacy at the University of Graz, receiving his doctorate in pharmaceutical chemistry in 1996. This was followed by a move to the University of Vienna, where, with the exception of a one-year postdoc at the University of Berkeley (from 1999 to 2000), his positi ... more
Heike Gerhardt studied chemistry at the universities of Tübingen and Vienna, already choosing to specialize in analysis during her master’s degree at the University of Vienna. She has worked at the University of Tübingen under Prof. Lämmerhofer since 2012: with her doctoral research work ne ... more
The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.
> more about q&more
q&more is supported by:
© 1997-2023 LUMITOS AG, All rights reserved
Authors
